Literature DB >> 18538610

Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice.

Zhongming Ge1, Torsten Sterzenbach, Mark T Whary, Barry H Rickman, Arlin B Rogers, Zeli Shen, Nancy S Taylor, David B Schauer, Christine Josenhans, Sebastian Suerbaum, James G Fox.   

Abstract

Helicobacter hepaticus strain 3B1 (H. hepaticus) contains a genomic island of approximately 71 kb, HHGI1, with some of the common features shared among known bacterial pathogenicity islands. In this study, we characterized the pathogenic potential of HHGI1 by infecting B6.129-IL10 tm1Cgn (IL10-/-) mice with an isogenic mutant (namely HhPAId1) lacking 19 predicted genes within HHGI1. In contrast to H. hepaticus (P<0.001), HhPAId1 did not cause typhlocolitis and hyperplasia in IL10-/- mice. Colonization levels of HhPAId1 were significantly higher in the cecum (P<0.007) and similar in the colon (P=0.27) when compared to H. hepaticus by 13 or 16 weeks post inoculation (WPI). The magnitude of the Th1-associated IgG2c response against HhPAId1 was less than that against H. hepaticus (P<0.004). There was no significant difference in Th2-associated IgG1 responses against these two strains. Cecal and colonic mRNA levels of proinflammatory cytokines IFN-gamma, TNF-alpha and IL-17a in the HhPAId1-infected mice were significantly lower than those in the H. hepaticus-infected mice (P<0.05) at 13 WPI. These results demonstrate that genes in the HHGI1 contribute to the pathogenicity of H. hepaticus, at least in part via up-regulation of proinflammatory mediators IFN-gamma, TNF-alpha and IL-17a.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538610      PMCID: PMC2583791          DOI: 10.1016/j.micinf.2008.03.011

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  30 in total

1.  Different Helicobacter hepaticus strains with variable genomic content induce various degrees of hepatitis.

Authors:  Samuel R Boutin; Zeli Shen; Arlin B Rogers; Yan Feng; Zhongming Ge; Sandy Xu; Torsten Sterzenbach; Christine Josenhans; David B Schauer; Sebastian Suerbaum; James G Fox
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

Authors:  S Censini; C Lange; Z Xiang; J E Crabtree; P Ghiara; M Borodovsky; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice.

Authors:  Zhongming Ge; Yan Feng; Mark T Whary; Prashant R Nambiar; Shilu Xu; Vivian Ng; Nancy S Taylor; James G Fox
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation.

Authors:  Kirk J Maurer; Melanie M Ihrig; Arlin B Rogers; Vivian Ng; Guylaine Bouchard; Monika R Leonard; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

5.  CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

Authors:  Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

6.  Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon.

Authors:  I B Autenrieth; M Beer; E Bohn; S H Kaufmann; J Heesemann
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism.

Authors:  M C Kullberg; J M Ward; P L Gorelick; P Caspar; S Hieny; A Cheever; D Jankovic; A Sher
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines.

Authors:  I B Autenrieth; V Kempf; T Sprinz; S Preger; A Schnell
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response.

Authors:  M T Whary; T J Morgan; C A Dangler; K J Gaudes; N S Taylor; J G Fox
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more
  9 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

2.  Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.

Authors:  Mark T Whary; Nancy S Taylor; Yan Feng; Zhongming Ge; Suresh Muthupalani; James Versalovic; James G Fox
Journal:  Immunology       Date:  2011-03-23       Impact factor: 7.397

3.  Hemorrhage-induced intestinal damage is complement-independent in Helicobacter hepaticus-infected mice.

Authors:  Diana J Hylton; Lauren M Phillips; Sara M Hoffman; Sherry D Fleming
Journal:  Shock       Date:  2010-11       Impact factor: 3.454

Review 4.  Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer.

Authors:  J G Fox; Z Ge; M T Whary; S E Erdman; B H Horwitz
Journal:  Mucosal Immunol       Date:  2010-10-13       Impact factor: 7.313

5.  A pathobiont of the microbiota balances host colonization and intestinal inflammation.

Authors:  Janet Chow; Sarkis K Mazmanian
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

6.  Genome sequence of the emerging pathogen Helicobacter canadensis.

Authors:  N J Loman; L A S Snyder; J D Linton; R Langdon; A J Lawson; G M Weinstock; B W Wren; M J Pallen
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

7.  Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis.

Authors:  Ines Yang; Daniel Eibach; Friederike Kops; Birgit Brenneke; Sabrina Woltemate; Jessika Schulze; André Bleich; Achim D Gruber; Sureshkumar Muthupalani; James G Fox; Christine Josenhans; Sebastian Suerbaum
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

8.  A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cells.

Authors:  Nadia Chaouche-Drider; Maria Kaparakis; Abdulgader Karrar; Maria-Isabel Fernandez; Letitia A M Carneiro; Jérôme Viala; Ivo Gomperts Boneca; Anthony P Moran; Dana J Philpott; Richard L Ferrero
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

9.  Comparative genomics analysis to differentiate metabolic and virulence gene potential in gastric versus enterohepatic Helicobacter species.

Authors:  Anthony Mannion; Zeli Shen; James G Fox
Journal:  BMC Genomics       Date:  2018-11-20       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.